B-B4 (radiolabeled with Iodine-131)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for B-B4 (radiolabeled with Iodine-131), covering 2011-03-22 to 2011-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 [Phase 1]